Ian Ingram from MedPage Today - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting		FDA Approves New Option for Rosacea - 13 days ago Lebrikizumab Wins FDA Approval for Eczema - 2 months ago ERS Roundup: Air Filtration Succeeds in Reducing Infections - 2 months ago Inhaled Antibiotic for Bronchiectasis Shows Benefit ... and Then It Doesn't - 2 months ago Cheap Antidepressant Flops for Severe Breathlessness in Trial - 2 months ago FDA Expands Durvalumab Label to Operable Lung Cancer - 3 months ago FDA OKs First Point-of-Care Test for Detecting Hep C in At-Risk Adults - 5 months ago FDA Approves Pneumococcal Vax Designed Specifically for Adults - 5 months ago Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study - 5 months ago Rare Pregnancy Problem Linked to Thiopurines, FDA Says - 7 months ago FDA Approves Earlier Use of CAR-T Products for Myeloma - 7 months ago Are Trump Voters Predisposed to COVID Vax Side Effects?! - 8 months ago New Monoclonal Authorized to Prevent COVID in Immunocompromised People - 8 months ago FDA Approves New Frontline Regimen for Aggressive ALL - 8 months ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 8 months ago Latest COVID Shots Protect Against Serious Outcomes - 9 months ago FDA OKs Amivantamab as First-Line Lung Cancer Treatment - 9 months ago FDA Approves First Drug for Severe Frostbite - 9 months ago FDA Approves First Oral Option for Eosinophilic Esophagitis - 9 months ago Bronchoscopes Recalled Over Burns, Fires in Patients' Airways - 11 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 11 months ago FDA OKs Maintenance Option for High-Risk Neuroblastoma - 11 months ago Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial - 11 months ago Pomalidomide Cuts Severe Epistaxis in Genetic Bleeding Disorder - 11 months ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - 11 months ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - 11 months ago Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients - 11 months ago Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials - 11 months ago Completely Oral Regimen Effective, Feasible in APL - 11 months ago Non-Covalent BTK Inhibitor Approved for CLL - 12 months ago Two Approaches for Infected Necrotizing Pancreatitis Go Head-to-Head - 12 months ago Higher-Dose Fluvoxamine Fails for COVID Outpatients - about 1 year ago First At-Home Test for Chlamydia and Gonorrhea Authorized by FDA - about 1 year ago Lymphoma Drug Copanlisib to Be Pulled From U.S. Market - about 1 year ago First Chikungunya Vaccine Lands Conditional FDA Approval - about 1 year ago New Oral Drug Approved for Metastatic Colorectal Cancer - about 1 year ago New Options Challenge Standard Treatments in EGFR-Mutant NSCLC - about 1 year ago Randomized Trial Backs HIF-2a Inhibition in Advanced RCC - about 1 year ago Tebentafusp's OS Benefit in Uveal Melanoma Holds Up at 3 Years - about 1 year ago